WRBY · Warby Parker Inc.
Market Cap
$3.11B
Shares
123.61M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$25.00
Open$25.24
Day$24.99–25.91
52W close$16.49–30.34
Avg vol 30d2.6M
Short int18.1M · 14.7% float · 5.5d
Short vol59%
Last earningsAug 6, 2026
DataSep 2021–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+1%
above
Price vs 50-day avg
−7%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
61%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−1%
trailing
YTD return
+15%
this year
Relative strength
−15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $27 › 200d $25 — 50d above 200d
Institutional flow
Distributing
-1% holders QoQ · +65 funds added
Insider flow
Distributing
Net -$265.3K over 90 days · 100% sells
Short interest
Rising
14.66% of float · ▲ +4.7% MoM · 5.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
303 holders — near 3-yr high, broad support
Squeeze score
65
elevated · 0–100
Fundamentals
Revenue growth
+13%
Y/Y
Gross margin
54%
contracting
EPS growth
+106%
Y/Y
Free cash flow
$43.7M
Buyback
$100.0M
authorized
Quant / Vol
risk profile
Volatility
75%
annualized · 1-yr
Max drawdown
−42%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Net revenue
· full year 2026
Maintained
$959M – $976M
May 7, 2026
$959M – $976M
changed to
Aug 6, 2026
$959M – $976M
prior FY $871.91M
midpoint +11.0% Y/Y
Adjusted EBITDA
· full year 2026
Non-GAAP
Maintained
$117M – $119M
Jun 30, 2026
$117M – $119M
changed to
Aug 6, 2026
$117M – $119M
Prior guidance
period ended
· from the Earnings Call filed Mar 31, 2026
Revenue
· second quarter
$235M – $238M
Adjusted EBITDA
· second quarter
$27M – $29M
Guided vs delivered
· last 8 settled
Revenue
second quarter
guided $235M – $238M
$235.51M
In line
Net revenue
full year 2025
guided $871M – $874M
$871.91M
In line
Net revenue
full year 2024
guided $765M – $768M
$771.32M
Beat +0.6%
Revenue
Q1 2024
guided $195.5M – $197M
$200M
Beat +1.9%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+1%
Bullish
Price vs 50-day avg
−7%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
61%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $27 › 200d $25 — 50d above 200d
Institutional flow
Distributing
-1% holders QoQ · +65 funds added
Insider flow
Distributing
Net -$265.3K over 90 days · 100% sells
Short interest
Rising
14.66% of float · ▲ +4.7% MoM · 5.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
303 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $16
Now $25 · 61%
Range high $30
vs 200-day avg +1%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Active Customers | 2.71M | Q2 2026 | — |
| Adjusted EBITDA non-GAAP | $32.9M | Q2 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net income (loss) 4.64M
-2.08M Interest and other income, net
+607K Provision for income taxes
+14.07M Depreciation and amortization expense
+163K Asset impairment charges
+10.33M Stock-based compensation expense
+3.95M Non-cash charitable donations
+1.04M Amortization of cloud-based software implementation costs
+0K System implementation costs
+0K Inventory write-downs
+165K Other costs
= Adjusted EBITDA 32.88M
|
|||
| Adjusted EBITDA Margin non-GAAP | 13.1% | Six Months Ended June 30 | — |
|
|
|||
| Adjusted Gross Profit non-GAAP | $136.9M | Q2 2026 | — |
| Adjusted SG&A non-GAAP | $119.3M | Q2 2026 | — |
|
|
|||
| Average Revenue per Customer | $336 | Q2 2026 | — |
|
|
|||
| Free Cash Flow non-GAAP | $6.8M | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities $29.62M
-$22.86M Purchases of property and equipment
= Free Cash Flow $6.76M
|
|||
| Net new stores opened | 15 | Q2 2026 | — |
|
|
|||
| Stores | 352 | Q2 2026 | — |
| Total stores | 337 | Q1 2026 | — |
| Active Customer growth | 7% | Full Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WRBY
this stock
Warby Parker Inc.
|
$3.11B | +14.7% | +13.0% | — | 14.7% |
|
ISRG
Intuitive Surgical Inc
|
$131.63B | -34.2% | +20.5% | 42.8 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$51.24B | — | +8.2% | — | 3.4% |
|
MDLN
Medline Inc.
|
$46.38B | -16.0% | +11.5% | — | 2.8% |
|
ALC
Alcon Inc
|
$34.83B | -8.6% | +10.5% | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WRBY | -8.9% | -6.3% | -1.1% | -6.3% | +14.7% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -9.4% | -9.3% | -14.5% | -9.3% | +1.9% |
Capital returns
Buyback program
· as of Feb 28, 2026
Authorized
$100.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1504776
CUSIP
93403J106
13F (30d)
246 filings
240 filers
Visit website
Investor relations